Data search
Results for MligTC455_41806
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_41806 | 792 | 16.49 | Mlig455_049483 | Neo: - Age: logFC(26M/2M)=-0.238 Region-enriched R8: 2.716/0.00000 |
PKD2 | Mlig455_049483 {REF} {Length: 3737} {Pfam: Polycystin cation channel [PF08016.14, score=493.1]; Ion transport protein [PF00520.33, score=89.6]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=712, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=694, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=709, Expect=0.0]; ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [Score=692, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=389, Expect=7e-124]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=747, Expect=0.0]} {RNA1509_31010, RNA1509_33992} {RNA1310_4653.1, RNA1509_33992} {RNA1509_33992, RNA815_4316} |
Cumulative graph for MligTC455_41806
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 1.754 | 4.014 | 0.03171 | 0.45238 | |
| RegionR2 | -0.73 | 4.014 | 0.13458 | 0.45552 | |
| RegionR3 | -1.664 | 4.014 | 0.00002 | 0.00135 | |
| RegionR4 | -1.618 | 4.014 | 0.00063 | 0.00726 | |
| RegionR5 | -2.245 | 4.014 | 0.00000 | 0.00000 | |
| RegionR6 | -0.345 | 4.014 | 0.35195 | 0.93677 | |
| RegionR7 | 2.132 | 4.014 | 0.00000 | 0.00000 | |
| RegionR8 | 2.716 | 4.014 | 0.00000 | 0.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -7.817 | 4.014 | 0.02719 | 0.61156 | |
| RegenerationR2 | 0.213 | 4.014 | 0.62649 | 0.92562 | |
| RegenerationR3 | 0.34 | 4.014 | 0.51065 | 0.86159 | |
| RegenerationR4 | -0.243 | 4.014 | 0.65009 | 0.93352 | |
| RegenerationR5 | 1.008 | 4.014 | 0.03850 | 0.32397 | |
| RegenerationR6 | -0.284 | 4.014 | 0.56285 | 0.84741 | |
| RegenerationBL | -1.544 | 4.014 | 0.00490 | 0.06485 | |
| RegenerationTP | -1.462 | 4.014 | 0.00242 | 0.08005 |
Genes with expression patterns similar to MligTC455_41806
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_41806 | 792 | 16.49 | Mlig455_049483 | Neo: - Age: logFC(26M/2M)=-0.238 Region-enriched R8: 2.716/0.00000 |
PKD2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_049483 {REF} {Length: 3737} {Pfam: Polycystin cation channel [PF08016.14, score=493.1]; Ion transport protein [PF00520.33, score=89.6]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=712, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=694, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=709, Expect=0.0]; ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [Score=692, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=389, Expect=7e-124]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=747, Expect=0.0]} {RNA1509_31010, RNA1509_33992} {RNA1310_4653.1, RNA1509_33992} {RNA1509_33992, RNA815_4316} |
| 2. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 4.171 | 0.958 | 0.847 | 0.865 | - | 0.724 | 0.777 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
| 3. | MligTC455_20407 | 5467 | 113.89 | Mlig455_054055 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.662 Region-enriched R7: 3.793/0.00000 Regeneration-downregulated BL: -5.435 Regeneration-depleted BL: -5.435 |
3.38 | 0.976 | 0.840 | - | 0.777 | - | 0.787 | Mlig455_054055 {REF} {Length: 1179} {RNA1509_40983} {RNA1310_94516} {RNA815_53532} | |
| 4. | MligTC455_20404 | 2355 | 49.05 | Mlig455_053980 | Neo: - Age: - Region-enriched R7: 4.495/0.00000 Regeneration-downregulated BL: -4.662 Regeneration-depleted BL: -4.662 |
3.304 | 0.971 | 0.816 | - | 0.805 | - | 0.712 | Mlig455_053980 {REF} {Length: 505} {NoTransDecoderORF} {RNA1509_5548} {RNA1310_94516} {RNA815_53532} | |
| 5. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
2.651 | 0.972 | 0.881 | - | - | - | 0.798 | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
| 6. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 2.609 | 0.976 | 0.806 | - | - | - | 0.827 | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
| 7. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 2.586 | 0.974 | 0.830 | - | - | - | 0.782 | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
| 8. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
2.578 | 0.963 | 0.804 | - | - | - | 0.811 | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
| 9. | MligTC455_48650 | 8593 | 179.02 | Mlig455_043924 | Neo: - Age: logFC(26M/2M)=-0.454 Region-enriched R8: 6.377/0.00000 |
2.55 | 0.972 | 0.731 | - | - | - | 0.847 | Mlig455_043924 {REF} {Length: 1776} {RNA1509_3829} {RNA1310_39915.1, RNA1509_3829} {RNA1509_3829, RNA815_21876} | |
| 10. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 2.535 | 0.961 | 0.750 | - | - | - | 0.824 | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
| 11. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
2.509 | 0.962 | 0.798 | - | - | - | 0.749 | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
| 12. | MligTC455_48954 | 316 | 6.59 | Mlig455_000336, Mlig455_067936 | Neo: - Age: - Region-enriched R8: 6.016/0.00000 |
WNT2 | 2.495 | 0.957 | 0.774 | 0.764 | - | - | - | Mlig455_000336 {REF} {Length: 2268} {Pfam: wnt family [PF00110.21, score=150.7]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=94.4, Expect=1e-20]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.8, Expect=3e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=95.1, Expect=4e-21]; ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [Score=93.2, Expect=2e-20]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=95.5, Expect=2e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=137, Expect=4e-36]} {RNA1509_39977} {RNA1310_11459, RNA1509_39977} {RNA1509_39977, RNA815_18855} Mlig455_067936 {REF} {Length: 2361} {Pfam: wnt family [PF00110.21, score=149.2]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=96.7, Expect=2e-21]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.0, Expect=6e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=97.4, Expect=7e-22]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=96.3, Expect=1e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=133, Expect=7e-35]} {RNA1509_39977} {RNA1310_11459} {RNA815_18855} |
| 13. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 2.423 | 0.963 | - | 0.731 | - | 0.729 | - | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
| 14. | MligTC455_31518 | 19118 | 398.29 | Mlig455_053864, Mlig455_053878 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=2.053 Region-enriched R8: 7.674/0.00000 |
PI16 | 2.401 | 0.950 | 0.710 | - | - | - | 0.741 | Mlig455_053864 {REF} {Length: 1794} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} Mlig455_053878 {REF} {Length: 1368} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 15. | MligTC455_31519 | 9556 | 199.07 | Mlig455_055347 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.365 Region-enriched R8: 7.870/0.00000 |
PI16 | 2.4 | 0.950 | 0.709 | - | - | - | 0.741 | Mlig455_055347 {REF} {Length: 1681} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.5]; Kringle domain [PF00051.20, score=52.7]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=84.3, Expect=2e-17]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=82.4, Expect=6e-17]} {Dmel: FBgn0038126, CG8483, [Score=97.4, Expect=2e-22]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.1, Expect=9e-12]} {Smed: dd_Smed_v6_433_0_1, dd_Smed_v6_433_0_1, [Score=111, Expect=3e-29]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 16. | MligTC455_31520 | 9547 | 198.9 | Mlig455_055402 | Neo: - Age: logFC(26M/2M)=-0.427 Region-enriched R8: 7.718/0.00000 |
PI16 | 2.4 | 0.950 | 0.709 | - | - | - | 0.741 | Mlig455_055402 {REF} {Length: 1363} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=27.4]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=69.3, Expect=4e-13]; ENSG00000173401, GLIPR1L1, GLIPR1 like 1, [Score=67.8, Expect=4e-13]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=71.2, Expect=7e-14]} {Dmel: FBgn0038126, CG8483, [Score=55.8, Expect=6e-09]} {Celegans: WBGene00009890, scl-9, SCP-Like extracellular protein, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_924_0_2, dd_Smed_v6_924_0_2, [Score=87.0, Expect=1e-21]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 17. | MligTC455_39644 | 439 | 9.15 | Mlig455_013029 | Neo: - Age: logFC(26M/2M)=1.036 Region-enriched R7: 6.439/0.00000 |
1.808 | 0.953 | 0.855 | - | - | - | - | Mlig455_013029 {REF} {Length: 544} {RNA1509_2705} {RNA1310_83617} {RNA815_52032} | |
| 18. | MligTC455_20097 | 1223 | 25.49 | Mlig455_023539, Mlig455_023644 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.339 Region-enriched R8: 3.355/0.00001 Regeneration-upregulated BL: 2.571 Regeneration-enriched BL: 2.571 |
1.757 | 0.981 | 0.776 | - | - | - | - | Mlig455_023539 {REF} {Length: 2548} {TRANSSPLICED} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206} {RNA815_15099} Mlig455_023644 {REF} {Length: 2780} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206, RNA1509_20731} {RNA1509_20731, RNA815_15099} |
|
| 19. | MligTC455_22921 | 848 | 17.66 | Mlig455_048030 | Neo: - Age: - Region-enriched R8: 6.496/0.00000 Regeneration-downregulated BL: -8.561 Regeneration-depleted BL: -8.561 |
CNTNAP1 | 1.753 | 0.973 | - | - | - | - | 0.780 | Mlig455_048030 {REF} {Length: 2506} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=31.2]; Spondin-like TSP1 domain [PF19028.2, score=23.9]; Thrombospondin type 1 domain [PF19030.2, score=20.8]} {Human: ENSG00000108797, CNTNAP1, contactin associated protein 1, [Score=65.5, Expect=3e-11]} {Mouse: ENSMUSG00000017167, Cntnap1, contactin associated protein-like 1, [Score=69.3, Expect=1e-12]} {Dmel: FBgn0013997, Nrx-IV, Neurexin IV, [Score=63.5, Expect=6e-11]} {Celegans: WBGene00003772, nlr-1, Neurexin Like receptor, [Score=60.8, Expect=3e-10]} {Smed: dd_Smed_v6_2622_0_1, dd_Smed_v6_2622_0_1, [Score=70.5, Expect=2e-13]} {RNA1509_12135} {RNA1310_13292} {RNA815_6015.1} |
| 20. | MligTC455_54245 | 82 | 1.71 | Mlig455_001318 | Neo: - Age: - |
PLA2G15 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_001318 {REF} {Length: 2950} {TRANSSPLICED} {Pfam: Lecithin:cholesterol acyltransferase [PF02450.17, score=201.0]; Serine aminopeptidase, S33 [PF12146.10, score=21.4]} {Human: ENSG00000103066, PLA2G15, phospholipase A2 group XV, [RH, Score=291, Expect=3e-94]} {Mouse: ENSMUSG00000031903, Pla2g15, phospholipase A2, group XV, [RH, Score=264, Expect=6e-84]; ENSMUSG00000035237, Lcat, lecithin cholesterol acyltransferase, [RH, Score=252, Expect=3e-79]} {Dmel: FBgn0042175, CG18858, [RH, Score=289, Expect=8e-94]} {Celegans: WBGene00010872, M05B5.4, [RH, Score=279, Expect=5e-90]} {Smed: dd_Smed_v6_1306_0_1, dd_Smed_v6_1306_0_1, [RH, Score=233, Expect=3e-72]} {RNA1509_8422, RNA1509_9827} {RNA1310_12728.2, RNA1509_9827} {RNA1509_9827, RNA815_7434.1} |
| 21. | MligTC455_37808 | 40 | 0.82 | Mlig455_055462 | Neo: - Age: - |
0.967 | - | - | - | - | - | 0.967 | Mlig455_055462 {REF} {Length: 3173} {RNA1509_32349} {RNA1310_84155} {RNA815_39182} | |
| 22. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 0.966 | 0.966 | - | - | - | - | - | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
| 23. | MligTC455_27472 | 133 | 2.77 | Mlig455_009912 | Neo: - Age: logFC(26M/2M)=-0.500 Region-enriched R8: 4.558/0.00009 |
ANK1 | 0.965 | 0.965 | - | - | - | - | - | Mlig455_009912 {REF} {Length: 4603} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=223.1]; Ankyrin repeat [PF00023.32, score=210.6]; Ankyrin repeats (many copies) [PF13637.8, score=152.3]; Ankyrin repeat [PF13606.8, score=151.1]; Ankyrin repeats (many copies) [PF13857.8, score=122.9]; Glutamine amidotransferase domain [PF13537.8, score=29.6]; Mab-21 protein [PF03281.16, score=29.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=194, Expect=1e-49]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=183, Expect=2e-46]; ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=181, Expect=9e-46]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=177, Expect=2e-44]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=171, Expect=1e-44]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=177, Expect=1e-44]} {Smed: dd_Smed_v6_2072_0_4, dd_Smed_v6_2072_0_4, [Score=187, Expect=5e-48]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
| 24. | MligTC455_37042 | 342 | 7.12 | Mlig455_067757 | Neo: - Age: - |
SYNGR1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_067757 {REF} {Length: 3170} {Pfam: Membrane-associating domain [PF01284.25, score=77.3]} {Human: ENSG00000100321, SYNGR1, synaptogyrin 1, [RH, Score=160, Expect=3e-48]} {Mouse: ENSMUSG00000022415, Syngr1, synaptogyrin 1, [RH, Score=161, Expect=9e-49]; ENSMUSG00000007021, Syngr3, synaptogyrin 3, [RH, Score=155, Expect=1e-46]} {Dmel: FBgn0033876, Syngr, Synaptogyrin, [RH, Score=143, Expect=6e-42]} {Smed: dd_Smed_v6_6478_0_1, dd_Smed_v6_6478_0_1, [RH, Score=202, Expect=6e-65]} {RNA1509_33915} {RNA1310_33819} {RNA815_10361.1} |
| 25. | MligTC455_34508 | 328 | 6.82 | Mlig455_053465 | Neo: Irradiation |
SLBP | 0.958 | - | - | - | 0.958 | - | - | Mlig455_053465 {REF} {Length: 2264} {TRANSSPLICED} {Pfam: Histone RNA hairpin-binding protein RNA-binding domain [PF15247.8, score=83.1]} {Human: ENSG00000163950, SLBP, stem-loop binding protein, [RH, Score=86.7, Expect=2e-19]} {Mouse: ENSMUSG00000004642, Slbp, stem-loop binding protein, [RH, Score=86.3, Expect=2e-19]} {Dmel: FBgn0041186, Slbp, Stem-loop binding protein, [RH, Score=77.0, Expect=6e-16]} {Celegans: WBGene00000411, cdl-1, Histone RNA hairpin-binding protein, [RH, Score=68.2, Expect=1e-12]} {Smed: dd_Smed_v6_9628_0_1, dd_Smed_v6_9628_0_1, [RH, Score=103, Expect=2e-25]} {RNA1509_27390, RNA1509_37378, RNA1509_43645} {RNA1310_22526.2, RNA1509_27390, RNA1509_37378, RNA1509_43645} {RNA1509_27390, RNA1509_37378, RNA1509_43645, RNA815_16079} |
| 26. | MligTC455_44220 | 119 | 2.49 | Mlig455_053870 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.322 Region-enriched R8: 4.672/0.00316 Regeneration-depleted BL: -8.794 |
CDH23 | 0.956 | 0.956 | - | - | - | - | - | Mlig455_053870 {REF} {Length: 7139} {Pfam: Cadherin domain [PF00028.19, score=356.1]; Cadherin-like [PF08266.14, score=28.2]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=370, Expect=4e-103]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=372, Expect=6e-104]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [Score=434, Expect=2e-124]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=240, Expect=2e-63]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=522, Expect=3e-155]} {RNA1509_44173, RNA1509_9298} {RNA1310_449.1, RNA1509_44173} {RNA1509_44173, RNA815_181} |
| 27. | MligTC455_04222 | 455 | 9.47 | Mlig455_056377 | Neo: - Age: Down-Down-Up Region-enriched R7: 2.703/0.00389 |
0.954 | - | - | 0.954 | - | - | - | Mlig455_056377 {REF} {Length: 2352} {Pfam: Innexin [PF00876.20, score=336.9]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=112, Expect=3e-27]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=231, Expect=3e-71]} {Smed: dd_Smed_v6_10766_0_1, dd_Smed_v6_10766_0_1, [RH, Score=357, Expect=1e-119]} {RNA1509_17737} {RNA1310_16884, RNA1509_17737} {RNA1509_17737, RNA815_8573} | |
| 28. | MligTC455_06328 | 144 | 3 | Mlig455_044820 | Neo: - Age: Down-Down-Up Region-enriched R8: 2.752/0.01310 Regeneration-downregulated BL: -7.394 Regeneration-depleted BL: -7.394 |
NOTCH4 | 0.95 | 0.950 | - | - | - | - | - | Mlig455_044820 {REF} {Length: 2669} {TRANSSPLICED} {Pfam: EGF-like domain [PF00008.29, score=37.2]; Human growth factor-like EGF [PF12661.9, score=29.7]; EGF-like domain [PF07974.15, score=19.8]} {Human: ENSG00000234876, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000204301, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000235396, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000223355, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000206312, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000232339, NOTCH4, notch 4, [Score=105, Expect=1e-22]; ENSG00000165124, SVEP1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=104, Expect=3e-22]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=92.4, Expect=1e-18]; ENSMUSG00000027878, Notch2, notch 2, [Score=90.1, Expect=6e-18]; ENSMUSG00000025020, Slit1, slit guidance ligand 1, [Score=89.7, Expect=7e-18]} {Dmel: FBgn0051665, wry, weary, [Score=115, Expect=3e-26]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=84.0, Expect=3e-16]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=107, Expect=1e-23]} {RNA1509_13430} {RNA1310_7596.1} {RNA815_13746} |
| 29. | MligTC455_28847 | 131 | 2.73 | Mlig455_045073 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_045073 {REF} {Length: 588} {RNA1509_57120} {RNA1310_63606.1} {RNA815_49827} |